{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:02:31Z","timestamp":1790776951047,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00842","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T04:58:06Z","timestamp":1574225886000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice"],"prefix":"10.3389","volume":"10","author":[{"given":"Palmiero","family":"Monteleone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderville","family":"Cabassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fagiolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuele A.","family":"Jannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Maina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Siracusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.04.019","article-title":"Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: a systematic review and meta-analysis","volume":"102","author":"Oakley","year":"2018","journal-title":"J Psychiatr Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/wps.20614","article-title":"The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials","volume":"18","author":"Vancampfort","year":"2019","journal-title":"World Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fpsyt.2018.00235","article-title":"LIFESTYLE Working Group. A Randomized Controlled Trial on the Efficacy of a Psychosocial Behavioral Intervention to Improve the Lifestyle of Patients With Severe Mental Disorders: Study Protocol","volume":"9","author":"Sampogna","year":"2018","journal-title":"Front Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-010-0112-8","article-title":"Metabolic syndrome associated with schizophrenia and atypical antipsychotics","volume":"10","author":"Hasnain","year":"2010","journal-title":"Curr Diabetes Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.schres.2006.06.026","article-title":"Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline","volume":"86","author":"Nasrallah","year":"2006","journal-title":"Schizophr Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S119632","article-title":"Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study","volume":"13","author":"Horsdal","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"key":"B8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-319-68306-5_8","article-title":"Psychosis, Antipsychotic Medication, and Sexual Dysfunctions","volume-title":"Sexual Dysfunctions in Mentally Ill Patients. Trends in Andrology and Sexual Medicine","author":"De Hert","year":"2018"},{"key":"B9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.psc.2016.01.008","article-title":"Detecting and Managing Adverse Effects of Antipsychotic Medications: Current State of Play","volume":"39","author":"Ames","year":"2016","journal-title":"Psychiatr Clin North Am"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the Pharmacotherapy of Schizophrenia in Adults","volume":"62","author":"Remington","year":"2017","journal-title":"Can J Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ap.27.2.104","article-title":"How to do research with self-administered surveys","volume":"27","author":"Sierles","year":"2003","journal-title":"Acad Psychiatry"},{"key":"B12","article-title":"A primer on web surveys","volume":"37","author":"Austin","year":"2008","journal-title":"J Allied Health"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X15666170630163616","article-title":"Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects","volume":"16","author":"Siafis","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291713002973","article-title":"Psychosis prevalence and physical, metabolic and cognitive co-morbidity: Data from the second Australian national survey of psychosis","volume":"44","author":"Morgan","year":"2014","journal-title":"Psychol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309115","article-title":"Decline in Cardiovascular Mortality: Possible Causes and Implications","volume":"120","author":"Mensah","year":"2017","journal-title":"Circ Res"},{"key":"B16","unstructured":"Addressing comorbidity between mental disorders and major noncommunicable diseases.2017"},{"key":"B17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12888-019-2248-7","article-title":"Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder","volume":"19","author":"Tan","year":"2019","journal-title":"BMC Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12888-016-1005-4","article-title":"Perceived needs and health-related quality of life in people with schizophrenia and metabolic syndrome: a \u201creal-world\u201d study","volume":"16","author":"Medeiros-Ferreira","year":"2016","journal-title":"BMC Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1701\/2484.25960","article-title":"Towards DSM 5.1. Proposals for schizophrenia","volume":"107","author":"Niolu","year":"2016","journal-title":"Recenti Prog Med"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1007\/978-88-470-2679-7_4","article-title":"Psychological Issues in Improving Adherence and Alliance","volume-title":"Adherence to Antipsychotics in Schizophrenia","author":"Niolu","year":"2014"},{"key":"B21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41537-018-0053-9","article-title":"Risk of weight gain for specific antipsychotic drugs: a meta-analysis","volume":"4","author":"Spertus","year":"2018","journal-title":"NPJ Schizophr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/acps.12445","article-title":"Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management","volume":"132","author":"Manu","year":"2015","journal-title":"Acta Psychiatr Scand"},{"key":"B23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/00332747.1958.11023115","article-title":"Developmental obesity and schizophrenia","volume":"21","author":"Bruch","year":"1958","journal-title":"Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fpsyt.2019.00251","article-title":"Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms","volume":"10","author":"Soontornniyomkij","year":"2019","journal-title":"Front Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archgenpsychiatry.2009.179","article-title":"Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA\/APA recommendations for second-generation antipsychotic drugs","volume":"67","author":"Morrato","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1720","article-title":"Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes","volume":"32","author":"Morrato","year":"2009","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20167","article-title":"Italian Network For Research on Psychoses. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia","volume":"13","author":"Galderisi","year":"2014","journal-title":"World Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00382-X","article-title":"Mental illness stigma as a quality-of-care problem","volume":"2","author":"Knaak","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009010","article-title":"Inequalities in physical comorbidity: a longitudinal comparative cohort study of people with severe mental illness in the UK","volume":"5","author":"Reilly","year":"2015","journal-title":"BMJ Open"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008650","article-title":"Primary care consultation rates among people with and without severe mental illness: a UK cohort study using the Clinical Practice Research Datalink","volume":"5","author":"Kontopantelis","year":"2015","journal-title":"BMJ Open"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v69n0401","article-title":"Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges","volume":"69","author":"Fleischhacker","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp016","article-title":"Substance use disorders in schizophrenia\u2013clinical implications of comorbidity","volume":"35","author":"Volkow","year":"2009","journal-title":"Schizophr Bull"},{"key":"B33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fpsyt.2018.00575","article-title":"Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical Practice","volume":"9","author":"Clerici","year":"2018","journal-title":"Front Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901410","article-title":"Inventories for male and female sexual dysfunctions","volume":"18","author":"Corona","year":"2006","journal-title":"Int J Impot Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.08.015","article-title":"Standards for Clinical Trials in Male and Female Sexual Dysfunction: II. Patient-Reported Outcome Measures","volume":"13","author":"Fisher","year":"2016","journal-title":"J Sex Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.128.10.1276","article-title":"Psychiatric disorders and sexual functioning","volume":"128","author":"Pinderhughes","year":"1972","journal-title":"Am J Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2019.04.001","article-title":"Medicine without sexual medicine is not medicine: An MJCSM and ESSM petition on sexual health to the political and university Authorities","volume":"16","author":"Jannini","year":"2019","journal-title":"J Sex Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.05.017","article-title":"Diagnosing Sexual Dysfunction in Men and Women: Sexual History Taking and the Role of Symptom Scales and Questionnaires","volume":"13","author":"Hatzichristou","year":"2016","journal-title":"J Sex Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2017.04.002","article-title":"SM = SM: The Interface of Systems Medicine and Sexual Medicine for Facing Non-Communicable Diseases in a Gender-Dependent Manner","volume":"5","author":"Jannini","year":"2017","journal-title":"Sex Med Rev"},{"key":"B41","first-page":"19","article-title":"Prevalence of cardiovascular risk factors in erectile dysfunction","volume":"5","author":"Walczak","year":"2002","journal-title":"J Gend Specif Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01412.x","article-title":"Metabolic syndrome and sexual (dys)function","volume":"6","author":"Borges","year":"2009","journal-title":"J Sex Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2015.12.034","article-title":"Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015","volume":"13","author":"McCabe","year":"2016","journal-title":"J Sex Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09638237.2019.1581333","article-title":"Sexual dysfunction in patients with schizophrenia and schizoaffective disorder and its association with adherence to antipsychotic medication","volume":"12","author":"Souaiby","year":"2019","journal-title":"J Ment Health"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2017.03.009","article-title":"Mating Strategies and Sexual Functioning in Personality Disorders: A Comprehensive Review of Literature","volume":"5","author":"Collazzoni","year":"2017","journal-title":"Sex Med Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.109.076489","article-title":"Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders","volume":"197","author":"Saarni","year":"2010","journal-title":"Br J Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2015.11.002","article-title":"Sexual dysfunction and its impact on quality of life in Chinese patients with schizophrenia treated in primary care","volume":"65","author":"Hou","year":"2016","journal-title":"Compr Psychiatry"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-68306-5_1","article-title":"Introduction: the need of sexual medicine in contemporary psychiatry and the need of psychiatry in the growing field of sexual medicine","volume-title":"Sexual Dysfunctions in Mentally Ill Patients.","author":"Jannini","year":"2018"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1708\/2098.22686","article-title":"Predictors of poor adherence to treatment in inpatients with bipolar and psychotic spectrum disorders","volume":"50","author":"Niolu","year":"2015","journal-title":"Riv Psichiatr"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12888-016-1172-3","article-title":"Psychiatric readmissions and their association with physical comorbidity: a systematic literature review","volume":"17","author":"\u0160prah","year":"2017","journal-title":"BMC Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.06.079","article-title":"Italian Network for Research on Psychoses. Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma","volume":"256","author":"Rossi","year":"2017","journal-title":"Psychiatry Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamapsychiatry.2017.4607","article-title":"Italian Network for Research on Psychoses. Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis","volume":"75","author":"Galderisi","year":"2018","journal-title":"JAMA Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00842\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T04:58:11Z","timestamp":1574225891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00842\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":52,"alternative-id":["10.3389\/fpsyt.2019.00842"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00842","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]},"article-number":"842"}}